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T
itin is a structural protein in muscle that
spans the half sarcomere from z-band to
M-line. Although there are selected studies on
titin’s mechanical properties from tests on isolated
molecules or titin fragments, little is known about
its behavior within the structural confines of a
sarcomere. Here, we tested the hypothesis that
titin properties might be reflected well in single
myofibrils. Therefore, the purpose of this study
was to measure the passive mechanical properties of
isolated single myofibrils and evaluate whether these
properties reflect the basic mechanical properties
of the titin molecule. Single myofibrils from
rabbit psoas were prepared for measurement of
passive stretch-shortening cycles at lengths where
passive titin forces become important. Three repeat
stretch-shortening cycles with magnitudes between
1.0-3.0µm/sarcomere were performed at a speed of
0.1µm/s·sarcomere and repeated after a ten minute
rest at zero force. These tests were performed in
a relaxation solution (passive) and an activation
solution (active) where cross-bridge attachment was
inhibited with butanedione monoxime. Myofibrils
behaved viscoelastically producing an increased
efficiency with repeat stretch-shortening cycles,
but a decreased efficiency with increasing stretch
magnitudes. Furthermore, we observed a first distinct
inflection point in the force-elongation curve at
an average sarcomere length of 3.5µm that was
associated with an average force of 68±5nN/mm−1.
This inflection point was thought to reflect Ig domain
unfolding and was missing after a ten minute rest at
zero force, suggesting a lack of spontaneous Ig domain
refolding. These passive myofibrillar properties
are consistent with those observed in isolated titin
molecules, suggesting that the mechanics of titin are
well preserved in isolated myofibrils, and thus, can
be studied readily in myofibrils, rather than in the
extremely difficult and labile single titin preparations.
Introduction
Titin (also known as connectin) is a giant structural
protein in muscle. It spans a half sarcomere from
the z-band to the M-line (Fig. 1) and has been
associated with passive force production in cardiac
and skeletal muscles. It has spring like properties
in its extensible I-band domain dominated by the
immunoglobulin (Ig) segments (both proximal and
distal), and the PEVK region, named so for its
predominance in proline (P), glutamate (E), valine
(V) and lysine (K) residues. Since its discovery in
the mid-1970s1,2, titin has emerged as an important
stabilizer of sarcomeres3,4, a producer of passive
force5,6, a regulator of active force7,8, and has been
associated with a variety of signaling, structural, and
mechanical properties9,10,11,12.
Titin is considered the third sarcomeric protein11,
and knowing its mechanical properties is essential for
explaining passive characteristics of muscles11,12,13,
force regulation during stretch7,8, sarcomere
stability3,4, and residual force enhancement in skeletal
muscles8,14,15. However, measuring titins mechanical
properties is difficult because the isolated protein is
highly unstable, and measuring its properties requires
specialized equipment. Nevertheless, Kellermayer
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Figure 1:
Schematic illustration of a sarcomere with the sarcomeric
filaments titin, actin, and myosin. Titin is anchored in
the z-lines of the sarcomere and extends to the M-band
in the middle of the sarcomere, thereby spanning a half
sarcomere. Because of its spring-like properties in the
I-band region, titin is perfectly positioned to stabilize the
myosin filaments in the centre of the sarcomere, provide
stability to sarcomeres (especially when stretched to long
lengths), and to act as a force modulator when sarcomeres
are stretched.
et al. were able to isolate titin and measure its
passive force-elongation properties using a laser
trap approach16. They found that titin had
a virtually elastic response below approximately
20pN1 and a highly viscoelastic response above
20pN. They also observed that energy loss in
passive stretch-shortening cycles decreased with
repeat stretch cycles, but increased with increasing
stretch magnitudes, and further observed a distinct
inflection point in the force-elongation curve which
they associated with the start of unfolding of the Ig
domain elements16 (see Fig. 2).
Although mechanical experiments of fractional
parts of recombinantly produced titin segments have
been performed successfully17,18,19, and have provided
crucial insights into the workings of this molecular
spring, full length mechanical experiments of titin
are rare16. Even with full length testing of titin,
there are a variety of limitations. These include the
uncertainties of the exact location of fixation of the
protein for mechanical measurement, the possibility
of measuring properties of multiple rather than single
titins, and the difficulty of relating isolated titin
properties to its function in the sarcomere, fibre
and muscle16. Therefore, the purpose of this study
was to measure the passive mechanical properties of
isolated single myofibrils and evaluate whether these
properties reflect the basic mechanical properties
of the titin molecule. If so, experiments at the
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Figure 2:
Force-elongation curves for isolated titin molecules. (A)
Titin behaves as an essentially elastic spring over short
extension distances (inset), but has a large hysteresis when
pulled beyond the point where Ig domains are thought to
unfold (point c). (B) Repeat force-elongation curves of a
titin molecule illustrating the loss of loading energy for
repeat cycles (A first cycle; B second cycle; C fifth cycle)
while the unloading energy remains less affected by repeat
stretch-shortening cycles (from Kellermayer et al.16: by
permission).
myofibrillar level might be used, as a much simpler
alternative to isolated protein tests in assessing
the mechanical properties of titin in its native and
structurally correct environment in different muscles
and under different mechanical loading conditions.
Methods
Preparation
Rabbit psoas myofibrils were used for testing.
Myofibrils were harvested from rabbit psoas,
chemically and mechanically isolated as described
in our previous works7,8,12,13, and prepared
for mechanical testing using micro-electronically
machined silicon nitride levers (stiffness 68 pN/nm)
for force measurement at one end of the myofibril
(resolution <0.5 nN), and a glass needle attached to
a motor for producing sub-nanometer step sizes at
the other end7,8,12,13 (Fig. 3).
Testing
Myofibrils (n=28) were passively stretched (see
relaxation solution in Joumaa et al, 200812) from a
nominal initial average sarcomere length of 2.5-2.7µm
by 1.0, 2.0, 2.5, and 3.0µm at a speed of 0.1
µm/s·sarcomere and then released at the same
speed to the original length. Three consecutive
stretch-shortening cycles were performed without
9
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Figure 3:
A. Photo micrograph of a myofibril attached to a glass needle (for imposing controlled displacements) at one end and
to a pair of nanolevers (for force measurements) at the other end (left panel). B. Close up view of a myofibril (right
panel top), and a single sarcomere (right panel middle), and schematic illustration of the three myofilament structure
of a sarcomere (right panel bottom).
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rest between cycles, followed by a ten minute
rest and repeat of the original stretch-shortening
protocol. For selected myofibrils (n=8), these same
stretch-shortening cycles (performed at a speed
of 0.1µm/s·sarcomere) were also performed using
an activating solution plus a cross-bridge inhibitor
(butanedione monoxime, BDM; see activation
solution with BDM in (Leonard and Herzog, 20108))
to test the passive properties of titin in an activation
medium with a saturated calcium concentration
(pCa2+ = 3.5).
Analysis
Peak force, loading energy (area under the force
elongation curve in the stretch phase), unloading
energy (area under the force-elongation curve in
the shortening phase), hysteresis or loss of energy
(difference between the loading and unloading
energies), change in stiffness (defined as the inflection
point of the force-elongation curve; that is where
the second derivative of this curve became zero),
shortest sarcomere length at the inflection point and
average force at the inflection point were all evaluated
for each myofibril. All values are given as means
and corresponding standard deviations. Statistical
differences for all outcome measures between the tests
performed passively (relaxation solution) and actively
with cross-bridge inhibition (activation solution with
BDM) were performed using the non-parametric
Mann-Whitney signed-rank test20. Changes in
outcome measures between the first, second and third
stretch-shortening cycle, and from the first set of
three cycles and the repeat set after ten minutes,
were performed using non-parametric Kruskal-Wallis
repeated measures testing20. All analyses were
performed using a level of significance of 0.05.
Results
Change in stiffness of force-elongation
curve
A distinct change in stiffness of the force-elongation
curves was observed in 8 of the 28 tested myofibrils
(Fig. 4). The smallest sarcomere length where this
was observed was 3.5µm while the average force
at this inflection point was 68 nN (±5 nN) when
normalized to 1.0µm of myofibril cross-sectional area.
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Figure 4:
Passive force-elongation curve of a single myofibril
showing a characteristic inflection point (arrow) as has
been found in tests using isolated titin molecules (inset
point c). This inflection point is thought to reveal the
length at which Ig domain unfolding starts to occur in
the sarcomeres of a myofibril. Note the similarity in
shape of the single molecule and single myofibril curves.
Sarcomere length is the mean length of all sarcomeres in
the myofibril.
Loss of energy (hysteresis)
Energy loss decreased significantly (p<0.05) from
the first to the second, and from the second to the
third repeat stretch-shortening cycle (Table 1 and
Fig. 5). This decrease was primarily associated with
a significant (p<0.05) decrease in loading energy,
while the unloading energies for repeat cycles also
decreased significantly (p<0.05) but to a much lesser
degree (Fig. 5). The energy loss for the first cycle
of the repeat testing set (10 minutes following the
first set) was significantly smaller (p<0.05) than the
first cycle of the initial set, but was similar (not
significantly different) to the third cycle of the original
set (Fig. 6). Finally, efficiency decreased with the
magnitude of stretch (p<0.05) from the smallest
(1.0µm) to the greatest stretch magnitude (3.0µm)
for all corresponding cycles (1st, 2nd and 3rd in Table
1).
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Table 1:
Mean (±1SD) percent efficiency of the three repeat stretch cycles of a test set as a function of the stretch magnitude
per sarcomere of passive myofibrils. Note that efficiency increases with increasing number of repeat stretch cycles and
decreases with increasing stretch magnitudes (as observed for single titin molecules).
Active vs. passive stretch-shortening tests
There were no differences in any of the outcome
measures for the tests performed using the relaxation
solution (passive tests) and the activation solution
(active tests) with the added cross-bridge inhibitor
(results not shown).
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Figure 5:
Force-elongation curves of three repeat stretch-shortening
cycles of a single myofibril illustrating the loss of loading
energy, the decrease in the hysteresis and the relatively
unchanged unloading energies from cycle 1 to cycle 3.
Note the similarity of the single myofibril curves with the
curves obtained from a single titin molecule (inset).
Discussion
Changes in stiffness
We observed a change in stiffness (inflection point)
of the myofibril force-elongation curves similar to
that seen in the isolated titin tests16. However,
this observation was only made for a sub-set of the
myofibrils. We think there might be two reasons for
this inconsistent observation: first, the attachment
of myofibrils and its handling prior to testing often
involved considerable stretching of the sarcomeres.
This stretching in the preparatory phase preceding
the actual tests might be responsible for unfolding
of some of the Ig domains (which we think are
the cause for the change in myofibril stiffness see
below), and if these Ig domains do not refold within
a short period of time (which we think they do not
see below), the change in stiffness could only be
observed in myofibrils that were prepared without
significant stretching of the sarcomeres prior to
testing. Second, we estimate that 1.0µm of cross
sectional area of a muscle contains approximately
2700 titin molecules6,21. Since sarcomere lengths
in a myofibril (like in a muscle) are non-uniform22,
one would expect titin Ig domain unfolding to
occur at different myofibril lengths for the individual
sarcomeres, and this might obscure the clear change
in stiffness observed in isolated titin preparations16.
The smallest mean sarcomere length at which
the change in stiffness in the first force-elongation
cycle occurred was 3.5µm. For subsequent cycles,
the inflection point occurred at increasingly longer
sarcomere lengths and slightly increasing myofibril
forces (Fig. 7). This result suggests that (i)
unfolding of the Ig domains occurs at approximately
3.5µm in rabbit psoas muscle, and (ii) that Ig
domain refolding is not complete in the shortening
phase, thereby shifting the start of unfolding of
Ig domains to greater average sarcomere lengths
12
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Figure 6:
Force-elongation curves for three repeat
stretch-shortening cycles of two sets of cycles separated
by ten minutes of rest at an average sarcomere length of
approximately 2.5µm. Note that the first cycle of the
second set has a substantially lower loading energy than
the first cycle of the first set suggesting that refolding of
the Ig domains was not completed in the ten minute rest
between sets. Similarly, the loading energies of the second
and third cycles of the second set are significantly smaller
than the corresponding cycles of the first set.
in repeat stretch-shortening cycles. This result is
in agreement with observation by Kellermayer who
found that Ig domain unfolding occurred at increasing
titin lengths for repeat stretch-shortening cycles (Fig.
2), and that Ig domain unfolding is incomplete if
stretch-shortening cycles occur without a break16.
The increase in Ig domain unfolding force with
repeat stretch cycles (Fig. 7) suggests that unfolding
strengths across Ig domains differ, thereby suggesting
structural differences across Ig domains.
Kellermayer et al. observed that Ig domain
unfolding occurred at a titin force of approximately
20-25pN16 (Fig. 2). In a myofibrillar cross-sectional
area of 1.0µm, one would expect approximately 2700
titin molecules (assuming a lattice spacing of 42nm
between thick filaments21 and 6 titin molecules per
half thick filament11. Multiplying the total number
of titin molecules in a myofibril by the force of
first Ig domain unfolding (20-25pN) provides an
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Figure 7:
Force-elongation curves for two first stretch-shortening
cycles that were separated by ten minutes. The inflection
point (where Ig domain unfolding is supposed to start -
arrows) is shifted to greater sarcomere lengths and
increased force for the second cycle suggesting that Ig
domain refolding did not occur in the ten minute rest
between trials, and that Ig domains have different
unfolding forces.
estimate of the myofibril force at which to expect
a force-elongation inflection point; that is about
54-68nN. The upper estimates of this theoretical
range agreed well with the mean myofibril force
(normalized to a 1.0µm cross-sectional area) where
we measured the inflection point in our myofibril
experiments (68±5nN). This good agreement between
the isolated titin and single myofibril results suggests
that the inflection point observed in the myofibril
experiments indeed corresponds to the point at which
titin Ig domain unfolding starts to occur. The average
sarcomere length of rabbit psoas with the hip fully
extended is 2.6µm (unpublished results). Therefore,
we conclude that Ig domain unfolding likely does not
occur during physiological use of the rabbit psoas
muscle.
Loss of energy
The loss of loading energy, but the relative
steady values for the unloading energy with repeat
stretch-shortening cycles, is also in good agreement
13
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with observations on single titin molecules16 (Fig.
2). The lack of recovery of the loading energy for
repeat stretch cycles, and indeed for repeat sets of
stretch cycles after a ten minute break (Fig. 6),
supports the observation that Ig domain unfolding is
incomplete within repeat stretch cycles and after
ten minutes of rest. We should emphasize here
that although our myofibrils were rested at a mean
sarcomere length of 2.5-2.7µm where passive forces
are zero, and thus no strain on titin is expected, this
length is at the very end of that encountered in the
normally functioning rabbit psoas (maximal in vivo
sarcomere length of about 2.6µm), thus refolding of Ig
domains might have been prevented here because of
the relatively long resting sarcomere lengths, despite a
zero passive force. Future experiments on the kinetics
of Ig domain refolding will need to focus on resting
sarcomeres for different periods of time at different
sarcomere lengths, as sarcomere length might have
a greater effect than passive force on titin refolding
when titin is within its mid-range within a sarcomere.
Active vs. passive stretch-shortening tests
Titin is known to have binding sites for calcium,
and it has been argued that calcium activation of
muscles affects the mechanical properties of titin by
increasing its stiffness8,12,23 and/or by modulating
its interaction with other sarcomeric proteins, such
as actin8,24,25,26,27. Based on this evidence, we
expected that there would be differences in the passive
forces measured in a low calcium relaxation solution
and a high (saturating) calcium activation solution
in which ”active” cross-bridge based forces were
chemically inhibited by BDM12. However, no such
differences were observed, which is in contrast to
previous reports12,23 but is consistent with some of
our most recent work8. In contrast to the work by
others12,23, our work here was performed at very long
sarcomere length. Possibly, calcium activation has
an effect on titin at short but not at long sarcomere
lengths, or the relatively small effects observed at
the short sarcomere lengths cannot be resolved at
long sarcomere lengths when passive myofibril forces
are in excess of 20 times greater than the observed
differences. This puzzle will need further attention
in the future, by measuring the effects of calcium
activation at short sarcomere lengths.
Conclusions
The results of this study suggest that the properties
of isolated titin molecules are well reflected in whole
myofibril testing. Titin properties appear to be well
preserved when titin operates within the structural
boundaries of a sarcomere. This result is exciting
insofar as passive myofibril testing is rather simple
compared to the complex isolation, stabilization and
mechanical testing of single titin proteins. Not only
is a myofibril approach much easier technically, it
also offers the advantage that titin can be studied in
its native environment and that titins properties can
be directly related to sarcomere forces and lengths,
and thus can be extrapolated to myofibril, fibre and
muscle properties.
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